Ahmetaj Erjon 13D and 13G filings for Immune Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-06-25 8:26 pm Unchanged |
2020-06-25 | 13G | Immune Therapeutics, Inc. IMUN |
Ahmetaj Erjon | 22 4.880% |
0 (Unchanged) |
Filing |